Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-14

Clinical Trial Update: Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in Treatment of First Episode Psychosis: 3-year Follow-up [Phase 4]

View source ↗

Summary

Phase 4 study reporting 3-year follow-up results comparing aripiprazole, quetiapine, and ziprasidone for first-episode psychosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ARIPIPRAZOLE (Aripiprazole)
  • Quetiapine (quetiapine)
  • Ziprasidone (ziprasidone)

Snippet

Sponsor: Fundación Marques de Valdecilla | Conditions: Schizophrenia, Psychotic Disorders | Phase 4 | Status: COMPLETED